RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
1-Year Return 25.98%
This Quarter Return
-4.26%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.49B
AUM Growth
-$101M
Cap. Flow
+$13.3M
Cap. Flow %
0.89%
Top 10 Hldgs %
30.22%
Holding
143
New
5
Increased
56
Reduced
18
Closed
10

Sector Composition

1 Healthcare 81.35%
2 Financials 4.56%
3 Industrials 0.44%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
FGEN icon
76
FibroGen
FGEN
$46.2M
$5.14M 0.34%
9,600
+260
+3% +$139K
CLVS
77
DELISTED
Clovis Oncology, Inc.
CLVS
$4.89M 0.33%
110,000
-15,000
-12% -$666K
MEDP icon
78
Medpace
MEDP
$13.5B
$4.87M 0.33%
135,000
ASMB icon
79
Assembly Biosciences
ASMB
$177M
$4.74M 0.32%
32,500
KDNY
80
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$4.73M 0.32%
83,000
MGNX icon
81
MacroGenics
MGNX
$124M
$4.6M 0.31%
225,000
STE icon
82
Steris
STE
$23.9B
$4.38M 0.29%
65,000
+25,000
+63% +$1.68M
CGEN icon
83
Compugen
CGEN
$133M
$4.21M 0.28%
825,000
XENT
84
DELISTED
Intersect ENT, Inc
XENT
$4.18M 0.28%
345,000
NVDQ
85
DELISTED
Novadaq Technologies Inc.
NVDQ
$3.94M 0.26%
555,000
AGN.PRA
86
DELISTED
Allergan plc.
AGN.PRA
$3.82M 0.26%
5,000
ALDR
87
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$3.79M 0.25%
182,000
FOLD icon
88
Amicus Therapeutics
FOLD
$2.46B
$3.77M 0.25%
757,500
+62,500
+9% +$311K
JUNO
89
DELISTED
Juno Therapeutics, Inc.
JUNO
$3.71M 0.25%
197,001
INVA icon
90
Innoviva
INVA
$1.33B
$3.61M 0.24%
336,900
KITE
91
DELISTED
Kite Pharma, Inc.
KITE
$3.54M 0.24%
79,000
OTIC
92
DELISTED
Otonomy, Inc.
OTIC
$3.34M 0.22%
210,000
CORV
93
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$3.31M 0.22%
1,200,000
NBRV
94
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$3.12M 0.21%
2,100
+396
+23% +$589K
CDTX icon
95
Cidara Therapeutics
CDTX
$1.64B
$3.12M 0.21%
15,000
+2,500
+20% +$520K
ARIA
96
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$3.11M 0.21%
250,000
+225,000
+900% +$2.8M
PBYI icon
97
Puma Biotechnology
PBYI
$256M
$2.9M 0.19%
94,500
+25,000
+36% +$767K
ITCI
98
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.87M 0.19%
190,000
TTPH
99
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.81M 0.19%
34,900
+1,775
+5% +$143K
ADAP
100
Adaptimmune Therapeutics
ADAP
$13.4M
$2.73M 0.18%
675,000